Background Cervical cancer is currently the leading cause of cancer mortality among
women in South Vietnam and the second leading cause of cancer mortality in North …

Objectives To evaluate the cost-effectiveness of the 9-valent human papillomavirus (HPV)
vaccine for the prevention of cervical cancer in China. Design Health economic modelling …

Background Human papillomavirus (HPV) vaccines have been proven effective against
cervical cancer. However, HPV vaccination is not included in the Chinese immunization …

Background Approximately 80% of cervical cancer cases occur in developing countries. In
Thailand, cervical cancer has been the leading cancer in females, with an incidence of 24.7 …

Background Although cervical cancer is a preventable disease, the clinical and economic
burdens of cervical cancer are still substantial issues in Indonesia. Objectives The main …

Objectives China suffers from high burdens of human papillomavirus (HPV) and cervical
cancer, whereas the uptake of HPV vaccine remains low. The first Chinese domestic HPV …

Abstract Background The World Health Organization (WHO) recommends that the cost
effectiveness of introducing human papillomavirus (HPV) vaccination is considered before …

Using mathematical models of cervical cancer for the northern and southern regions of
Vietnam, we assessed the cost-effectiveness of cervical cancer prevention strategies and …

Using WHO-CHOICE methodology, we calculated cost–utility ratios for various interventions
(PAP smear, HPV-DNA testing, VIA and vaccination against HPV) at various frequencies to …

Abstract Background: The Thai healthcare setting has seen patients with cervical cancer
experience an increasing burden of morbidity and mortality, a stagnation in the performance …